首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Porcine model to evaluate local tissue tolerability associated with subcutaneous delivery of protein
【24h】

Porcine model to evaluate local tissue tolerability associated with subcutaneous delivery of protein

机译:猪模型用于评估与皮下递送蛋白质相关的局部组织耐受性

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: The conversion from intravenous (IV) to subcutaneous (SC) delivery of biotherapeutics has increased in recent years. Some of the reasons for this shift in route of delivery are due to patient convenience, reduced adverse systemic effects, lack of a need for vascular access, and reduced cost of patient care, which ultimately lead to improved patient quality of life. One caveat to SC delivery is the limited volumes that can be administered at a single site and the associated local tolerability. To characterize factors that affect subcutaneous delivery of large volumes of therapeutic proteins, a porcine model was developed. Model endpoints included measurement of interstitial pressure, assessment of local skin visco-elasticity, and the qualitative assessment of local infusion sites. Methods: Immunoglobulin G (IgG) was subcutaneously infused into the abdominal region of Yucatan miniature swine. Changes in interstitial pressure were measured, using an in-line pressure transducer, during and after infusions. Additionally, pre- and post-infusion changes in local skin visco-elasticity were measured using a Cutometer?. Lastly, infusion sites were assessed for post-infusion local skin reactions such as erythema and swelling. Similar assessments were made following SC IgG delivery with the permeation enhancer recombinant human hyaluronidase PH20 (rHuPH20). Results: Subcutaneous infusions of IgG, in the presence of rHuPH20, significantly reduced average interstitial pressures by 55% during the infusion period and by 67% during the post-infusion period, compared to the control. Infusions in the presence of rHuPH20 also maintained better local skin elasticity as seen by a 42% increase in local skin pliability compared to the control. Finally, infusions with rHuPH20 resulted in an 80% reduction in swelling area compared to the control. Discussion: A large animal model was developed that incorporates both quantitative and qualitative assessment methods to aid in understanding SC delivery of proteins.
机译:简介:近年来,从生物治疗的静脉内(IV)到皮下(SC)递送的转化有所增加。这种转移途径改变的一些原因是由于患者的便利,减少的不利全身作用,对血管通路的需求减少以及患者护理的成本降低,这最终导致患者生活质量的改善。 SC交付的一个警告是可以在单个站点进行管理的有限数量以及相关的局部耐受性。为了表征影响皮下递送大量治疗性蛋白质的因素,建立了猪模型。模型终点包括组织间压的测量,局部皮肤粘弹性的评估以及局部输注部位的定性评估。方法:将免疫球蛋白G(IgG)皮下注入尤卡坦小型猪的腹部。在输注期间和输注后,使用在线压力传感器测量组织间压力的变化。另外,使用Cutometer?测量输注前后皮肤局部粘弹性的变化。最后,评估输注部位的输注后局部皮肤反应,如红斑和肿胀。用渗透增强剂重组人透明质酸酶PH20(rHuPH20)递送SC IgG后,进行了类似的评估。结果:与对照组相比,在存在rHuPH20的情况下皮下输注IgG可以使输注期间的平均组织压力显着降低55%,输注后平均降低67%。与对照相比,在rHuPH20存在下的输注也保持了更好的局部皮肤弹性,这是通过使局部皮肤柔韧性提高了42%看到的。最后,与对照相比,输注rHuPH20导致肿胀面积减少80%。讨论:开发了一个大型动物模型,该模型结合了定量和定性评估方法,有助于理解蛋白质的SC递送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号